Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS · BSE: 524412 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹101.57
Market cap: ₹288.0 Cr
Revenue (annual): ₹472.3 Cr
Net profit (annual): ₹3.97 Cr
P/E (TTM): 69.0×Sector 50.4×
Promoter holding: 42.79%+5.08% QoQ
FII holding: 4.41%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Other Announcement 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

7 Sep 2026 19:30 IST BSE

Other Announcement

Aarey Drugs & Pharmaceuticals Other Announcement

Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern. This is a routine regulatory compliance disclosure regarding the company's equity distribution.

Read the filing ↗

5 Sep 2026 19:56 IST BSE

Annual General Meeting

Aarey Drugs & Pharmaceuticals Annual General Meeting

Aarey Drugs approved the Board Report and called its 36th Annual General Meeting to be held on September 30, 2026.

Read the filing ↗

14 Aug 2026 20:29 IST BSE

Financial Results

Aarey Drugs & Pharmaceuticals Q1 FY27 Results: Net Profit ₹1 Cr, Down 28.6% YoY

Aarey Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹44.6 Cr (-56.4% YoY) and net profit of ₹1 Cr (-28.6% YoY) for Q1 FY27.

Key figure: Net profit ₹1 Cr · -28.6% YoY

Open full results → Read the filing ↗

30 May 2026 19:39 IST BSE

Financial Results

Aarey Drugs & Pharmaceuticals Q4 FY26 Results: Net Profit ₹1.6 Cr, Up 220.0% YoY

Aarey Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹189.5 Cr (+75.3% YoY) and net profit of ₹1.6 Cr (+220.0% YoY) for Q4 FY26.

Key figure: Net profit ₹1.6 Cr · +220.0% YoY

Open full results → Read the filing ↗